Background Differentiated thyroid cancer (DTC) reports a poorer health‐related quality of life
(HRQoL) than a norm population. Patients' illness perceptions are modifiable and known …

Background. Given the longevity of thyroid cancer patients, any impairment in health-related
quality of life (HRQoL) during the follow-up period is of considerable concern. Therefore, the …

Background: Patients with malignancy suffer impairment of their quality of life (QoL). QoL
has been evaluated in thyroid cancer patients. Since 2010, a new inventory, the thyroid …

Background: Although differentiated thyroid cancer (DTC) has an excellent prognosis and a
low incidence of recurrence, lifelong follow-up and medication might be needed. The aim of …

Background: Patients with differentiated thyroid cancer (DTC) usually have a good
prognosis but may experience a decline in quality of life (QOL). The way patients perceive …

Background: Differentiated thyroid cancer (DTC) has a good prognosis but a remaining risk
of recurrence and need for lifelong follow-up. The aim was to study changes in health …

Background. To date, no valid instrument is available that focuses on specific health-related
quality of life (HRQoL) issues that affect thyroid cancer survivors. The objective of this study …

Background: Differentiated thyroid cancer (DTC) has a good prognosis but a remaining risk
of recurrence, and life-long follow-up as well as medication with levothyroxine may be …

Background: The incidence of differentiated thyroid cancer in Mainland China has increased
rapidly in recent years, yet the number of studies focusing on health-related quality of life …

Background: Health-related quality of life (HRQoL) is important for differentiated thyroid
cancer survivors, but data for Asian survivors is lacking. This study aimed to have an …